eli lilly sleep apnea news

Eli Lilly, obstructive sleep apnea and FDA

FDA approves Eli Lilly’s obesity medication for obstructive sleep apnea

The FDA has expanded the approval of Eli Lilly’s obesity medication Zepbound to include treating moderate to severe obstructive sleep apnea for people with obesity.

Investopedia on MSN · 4d

Sleep Apnea Device Maker Stocks Slide on FDA Ruling for Eli Lilly's Zepbound

Key Takeaways Shares of ResMed and Inspire Medical Systems fell after the FDA approved Eli Lilly's weight-loss drug Zepbound to treat moderate-to-severe obstructive sleep apnea in adults with obesity.

The Wall Street Journal on MSN · 5d

Eli Lilly Gets FDA Approval for Zepbound for Certain Sleep Apnea Patients

Eli Lilly said the FDA approved Zepbound for moderate-to-severe obstructive sleep apnea in adults with obesity, the first and only prescription medicine for those suffering from this condition.

USA Today7d

The Food and Drug Administration on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and obesity. Zepbound is the first medication ...

SchaeffersResearch.com5d

2 Sleep Apnea Stocks in Focus Today

Eli Lilly and Co (NYSE:LLY) is in focus today, after the U.S. Food & Drug Administration (FDA) approved its weight-loss drug, Zepbound, to treat obstructive sleep apnea in adults with obesity ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Eli Lilly, obstructive sleep apnea and FDA

Trending now